|
1
|
Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu
C and Li Y: Epidemiological trends in colorectal cancer in China:
An ecological study. Dig Dis Sci. 62:235–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marcus DA: Epidemiology of cancer pain.
Curr Pain Headache Rep. 15:231–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gomes T, Juurlink DN, Dhalla IA,
Mailis-Gagnon A, Paterson JM and Mamdani MM: Trends in opioid use
and dosing among socio-economically disadvantaged patients. Open
Med. 5:e13–e22. 2011.PubMed/NCBI
|
|
4
|
Hynninen MS, Cheng DC, Hossain I, Carroll
J, Aumbhagavan SS, Yue R and Karski JM: Non-steroidal
anti-inflammatory drugs in treatment of postoperative pain after
cardiac surgery. Can J Anaesth. 47:1182–1187. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lahtinen P, Kokki H, Hendolin H, Hakala T
and Hynynen M: Propacetamol as adjunctive treatment for
postoperative pain after cardiac surgery. Anesth Analg. 95:813–819.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parikh B, Maliwad J and Shah VR:
Preventive analgesia: Effect of small dose of ketamine on morphine
requirement after renal surgery. J Anaesthesiol Clin Pharmacol.
27:485–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerr C, Holahan T and Milch R: The use of
ketamine in severe cases of refractory pain syndromes in the
palliative care setting: A case series. J Palliat Med.
14:1074–1077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Umansky V: Immunosuppression in the tumor
microenvironment: Where are we standing? Semin Cancer Biol.
22:273–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Draghiciu O, Nijman HW and Daemen T: From
tumor immunosuppression to eradication: Targeting homing and
activity of immune effector cells to tumors. Clin Dev Immunol.
2011:4390532011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Munhoz RR and Postow MA: Recent advances
in understanding antitumor immunity. F1000Res. 5:25452016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Protti MP, De Monte L and Di Lullo G:
Tumor antigen-specific CD4+T cells in cancer immunity: From antigen
identification to tumor prognosis and development of therapeutic
strategies. Tissue Antigens. 83:237–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kurosawa S and Kato M: Anesthetics, immune
cells, and immune responses. J Anesth. 22:263–277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tosolini M, Kirilovsky A, Mlecnik B,
Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH,
Pagès F and Galon J: Clinical impact of different classes of
infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in
patients with colorectal cancer. Cancer Res. 71:1263–1271. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ubukata H, Motohashi G and Tabuchi T,
Nagata H, Konishi S and Tabuchi T: Evaluations of
interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as
prognostic indicators in gastric cancer patients. J Surg Oncol.
102:742–747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hunter JD: Effects of anaesthesia on the
human immune system. Hosp Med. 60:658–663. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao M, Jin W, Qian Y, Ji L, Feng G and Sun
J: Effect of N-methyl-D-aspartate receptor antagonist on T helper
cell differentiation induced by phorbol-myristate-acetate and
ionomycin. Cytokine. 56:458–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao M, Sun J, Jin W and Qian Y: Morphine,
but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive
cells through T-bet and GATA3. Inflammation. 35:1069–1077. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nicholl DS, Daniels HM, Ira Thabrew M,
Grayer RJ, Simmonds MS and Hughes RD: In vitro studies on the
immunomodulatory effects of extracts of Osbeckia aspera. J
Ethnopharmacol. 78:39–44. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abbas AK, Murphy KM and Sher A: Functional
diversity of helper T lymphocytes. Nature. 383:787–793. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Adotévi O, Dosset M, Galaine J, Beziaud L,
Godet Y and Borg C: Targeting antitumor CD4 helper T cells with
universal tumor-reactive helper peptides derived from telomerase
for cancer vaccine. Hum Vaccin Immunother. 9:1073–1077. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan YY: Multi-tasking of helper T cells.
Immunology. 130:166–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Olson NC, Sallam R, Doyle MF, Tracy RP and
Huber SA: T helper cell polarization in healthy people:
Implications for cardiovascular disease. J Cardiovasc Transl Res.
6:772–786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Evans CF, Galustian C, Bodman-Smith M,
Dalgleish AG and Kumar D: The effect of colorectal cancer upon host
peripheral immune cell function. Colorectal Dis. 12:561–569. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanazawa M, Yoshihara K, Abe H, Iwadate M,
Watanabe K, Suzuki S, Endoh Y, Takita K, Sekikawa K, Takenoshita S,
et al: Effects of PSK on T and dendritic cells differentiation in
gastric or colorectal cancer patients. Anticancer Res. 25:443–449.
2005.PubMed/NCBI
|
|
25
|
Tabata T, Hazama S, Yoshino S and Oka M:
Th2 subset dominance among peripheral blood T lymphocytes in
patients with digestive cancers. Am J Surg. 177:203–208. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Domino EF, Zsigmond EK, Domino LE, Domino
KE, Kothary SP and Domino SE: Plasma levels of ketamine and two of
its metabolites in surgical patients using a gas chromatographic
mass fragmentographic assay. Anesth Analg. 61:87–92. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Atkins D, Best D, Briss PA, Eccles M,
Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry
D, et al: Grading quality of evidence and strength of
recommendations. BMJ. 328:14902004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hammoud HA, Aymard G, Lechat P,
Boccheciampe N, Riou B and Aubrun F: Relationships between plasma
concentrations of morphine, morphine-3-glucuronide,
morphine-6-glucuronide, and intravenous morphine titration outcomes
in the postoperative period. Fundam Clin Pharmacol. 25:518–527.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pala P, Hussell T and Openshaw PJ: Flow
cytometric measurement of intracellular cytokines. J Immunol
Methods. 243:107–124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Whiteside TL: Cytokine assays.
Biotechniques Suppl. 4-8(10): 12–15. 2002.
|
|
31
|
Freer G and Rindi L: Intracellular
cytokine detection by fluorescence-activated flow cytometry: Basic
principles and recent advances. Methods. 61:30–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mackenzie NM and Pinder AC: Flow cytometry
and its applications in veterinary medicine. Res Vet Sci.
42:131–139. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Foster B, Prussin C, Liu F, Whitmire JK
and Whitton JL: Detection of intracellular cytokines by flow
cytometry. Curr Protoc Immunol Chapter. 6:Unit 6.24. 2007.
View Article : Google Scholar
|
|
34
|
Papadogiannakis EI, Kontos VI, Tamamidou M
and Roumeliotou A: Determination of intracellular cytokines
IFN-gamma and IL-4 in canine T lymphocytes by flow cytometry
following whole-blood culture. Can J Vet Res. 73:137–143.
2009.PubMed/NCBI
|
|
35
|
Palma-Nicolás JP, Hernández-Pando R,
Segura E, Ibarra-Sánchez MJ, Estrada-García I, Zentella-Dehesa A
and López-Marín LM: Mycobacterial di-O-acyl trehalose inhibits Th-1
cytokine gene expression in murine cells by down-modulation of MAPK
signaling. Immunobiology Immunobiology signaling. Immunobiology.
215:143–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
